PRESS-RELEASE ·Filed May 4, 2026

CHRS

Coherus Oncology, Inc.
NEUTRAL
Impact 1/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight • Neutral

Monitor the upcoming Q1 2026 earnings release on May 11 for actual financial results and guidance. No immediate trading action warranted based on this filing.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CHRS ▼ -18.50% at T+60d
NEUTRAL call ✗ call lost -18.50% · α vs SPY -20.35% · entry $1.73 → $1.41
Entry anchored
May 1, 03:59 PM ET
via exchange tick
T+1d
+3.47%
call +3.47% · α +2.67%
$1.79
settled 5mo ago
T+5d
+12.72%
call +12.72% · α +9.78%
$1.95
settled 5mo ago
T+20d
-9.25%
call -9.25% · α -14.89%
$1.57
settled 4mo ago
T+60d
-18.50%
call -18.50% · α -20.35%
$1.41
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Coherus Oncology issued a press release announcing that its Q1 2026 financial results will be released after market close on May 11, 2026, with a conference call at 5:00 PM ET. No financial results were disclosed in this filing.

Key Facts

  • Q1 2026 earnings release scheduled for May 11, 2026 after market close
  • Conference call at 5:00 PM ET on May 11, 2026
  • No financial data provided in this announcement

Financial Impact

None — date announcement only

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3286820
11 reports for CHRS
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +16.97%Feb 28, 2026
Filters
Rows
Reports for CHRS — sortable, filterable
TypeNow
Aug 17, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$1.34 $1.29▼ −4.10%▼ −3.11%$1.16 (−13.43%)
Jul 22, 2026
10w ago
Press Release
NEUTRAL ★ 1/10
$1.43 $1.33▼ −6.99%▼ −9.89%$1.16 (−18.88%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$1.38 $1.45▲ +5.07%▲ +4.87%$1.16 (−15.94%)
Jun 12, 2026
16w ago
Institutional Cluster
BEARISH ★ 4/10
$1.40 $1.54▼ −10.00%▼ −8.22%$1.16 (+17.14%)
May 28, 2026
18w ago
DEFA14A
NEUTRAL ★ 4/10
$1.65 $1.50▼ −9.09%▼ −5.95%$1.16 (−29.70%)
May 11, 2026
20w ago
Press Release
MIXED ★ 6/10
$1.71 $1.36▼ −20.47%▼ −18.74%$1.16 (−32.16%)
May 5, 2026
21w ago
DEFA14A
NEUTRAL ★ 2/10
$1.75 $1.47▼ −16.00%▼ −18.78%$1.16 (−33.71%)
May 4, 2026
21w ago
Press Release
NEUTRAL ★ 1/10
$1.73 $1.57▼ −9.25%▼ −14.89%$1.16 (−32.95%)
Mar 9, 2026
29w ago
Press Release
BULLISH ★ 8/10
$1.95 $1.70▼ −12.82%▼ −12.67%$1.16 (−40.51%)
Mar 2, 2026
30w ago
Press Release
NEUTRAL ★ 3/10
$1.65 $1.60▼ −3.03%▲ +4.91%$1.16 (−29.70%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 4, 2026